Posted by Michael Wonder on 15 May 2023
Medicare, FDA urged to press ahead with new Alzheimer’s drug Leqembi
12 May 2023 - Patients, law makers and Alzheimer’s advocates are pushing for Medicare to fully cover a new drug for treating early stage Alzheimer’s.
The FDA granted accelerated approval to Eisai’s Alzheimer’s drug Leqembi in January. The drug has been shown to moderately slow the progression of the disease in its early stages.
